Skip to main content

Table 1 Patient characteristics in NYU study patients

From: Is there an androgen level threshold for aneuploidy risk in infertile women?

  n Mean SD or 95% CI
Age (years) 84 40.30 2.44
Day-2 FSH (IU/mL) 84 6.64 2.37
Day-2 E2 (pg/mL) 84 43.10* 38.82 - 47.77*
AMH (ng/mL) 69 1.77* 1.47 - 2.13*
Total gonanadtropins (IU) 83 4,098 1380
     FSH (IU) 83 2,646 1138
     HMG (IU) 83 1,451 889
Days to hCG trigger 83 9.55 1.59
E2 on day of trigger (pg/mL) 83 2282* 2066 - 2522*
Number of oocytes 84 13.35* 11.97 - 14.88*
Number of MII oocytes 84 11.85 6.13
     2PN oocytes 84 7.76* 6.84 - 8.80*
DHEA (ng/dL) 84 294.7* 257.5 – 337.4*
Androstenedione (ng/dL) 84 60.1* 55.8 – 64.6*
Total testosterone (ng/dL) 84 16.7* 15.4 – 18.1*
Number of euploid embryos 84 1.51 1.81
Number of aneuploid embryos 84 3.62 2.93
Embryos with no diagnosis 84 0.31 1.01
Ploidy Index 84 0.29 0.29
  1. *Denotes P<0.05.